Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2


Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
17 08 2021
Historique:
pubmed: 8 6 2021
medline: 24 8 2021
entrez: 7 6 2021
Statut: ppublish

Résumé

Antivirals targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could improve treatment of COVID-19. We evaluated the efficacy of clinically relevant hepatitis C virus (HCV) NS3 protease inhibitors (PIs) against SARS-CoV-2 and their interactions with remdesivir, the only direct-acting antiviral approved for COVID-19 treatment. HCV PIs showed differential potency in short-term treatment assays based on the detection of SARS-CoV-2 spike protein in Vero E6 cells. Linear PIs boceprevir, telaprevir, and narlaprevir had 50% effective concentrations (EC

Identifiants

pubmed: 34097489
doi: 10.1128/AAC.02680-20
pmc: PMC8370243
doi:

Substances chimiques

Antiviral Agents 0
Protease Inhibitors 0
Spike Glycoprotein, Coronavirus 0
Viral Protease Inhibitors 0
spike protein, SARS-CoV-2 0
remdesivir 3QKI37EEHE
Adenosine Monophosphate 415SHH325A
Alanine OF5P57N2ZX

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0268020

Subventions

Organisme : Candys Foundation
Organisme : Candys Foundation
Organisme : Candys Foundation
Organisme : Candys Foundation
Organisme : Købmand I Odense Johan og Hanne Weimann Født Seedorffs Legat (Købmand i Odense Johann og Hanne Weimann født Seedorffs Legat)
Organisme : Ministry of Science, Innovation and Higher Education | Danish Agency for Science and Higher Education (Danish Agency for Science, Technology and Innovation)
Organisme : Ministry of Science, Innovation and Higher Education | Danish Agency for Science and Higher Education (Danish Agency for Science, Technology and Innovation)
Organisme : Ministry of Science, Innovation and Higher Education | Danish Agency for Science and Higher Education (Danish Agency for Science, Technology and Innovation)
Organisme : Novo Nordisk Fonden (NNF)

Références

Gastroenterology. 2014 Mar;146(3):812-821.e4
pubmed: 24262279
Molecules. 2020 May 29;25(11):
pubmed: 32485894
Comput Biol Med. 2020 Jul;122:103848
pubmed: 32658735
Antimicrob Agents Chemother. 2013 Dec;57(12):6034-49
pubmed: 24060868
J Biomol Struct Dyn. 2021 May;39(8):2679-2692
pubmed: 32266873
J Biomol Struct Dyn. 2020 Jul 20;:1-23
pubmed: 32686993
Antimicrob Agents Chemother. 2009 Apr;53(4):1377-85
pubmed: 19171797
Structure. 2020 Dec 1;28(12):1313-1320.e3
pubmed: 33152262
J Virol. 1995 Apr;69(4):2534-9
pubmed: 7884903
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Nat Commun. 2020 Sep 4;11(1):4417
pubmed: 32887884
Antimicrob Agents Chemother. 2015 Dec;59(12):7426-36
pubmed: 26392503
J Med Virol. 2020 Jun;92(6):568-576
pubmed: 32134116
Signal Transduct Target Ther. 2020 May 9;5(1):67
pubmed: 32388537
J Pharm Drug Res. 2020;3(2):341-361
pubmed: 32617527
Gastroenterology. 2011 Sep;141(3):1067-79
pubmed: 21699793
ACS Cent Sci. 2021 May 26;7(5):792-802
pubmed: 34075346
Nat Commun. 2021 Feb 2;12(1):743
pubmed: 33531496
Comb Chem High Throughput Screen. 2021;24(3):441-454
pubmed: 32748740
J Mol Struct. 2020 Dec 15;1222:128878
pubmed: 32834113
Antimicrob Agents Chemother. 2016 May 23;60(6):3563-78
pubmed: 27021330
J Virol. 2010 May;84(9):4597-610
pubmed: 20164226
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Cell Res. 2020 Mar;30(3):269-271
pubmed: 32020029
Hepatology. 2011 Apr;53(4):1090-9
pubmed: 21480315
Cell Res. 2020 Aug;30(8):678-692
pubmed: 32541865
Infect Genet Evol. 2020 Oct;84:104451
pubmed: 32640381
J Viral Hepat. 2011 May;18(5):305-15
pubmed: 21470343
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Med Res Rev. 2018 Jul;38(4):1295-1331
pubmed: 29149530
Sci Rep. 2020 Oct 19;10(1):17716
pubmed: 33077821
Hepatology. 2014 Feb;59(2):395-407
pubmed: 23913364
Antiviral Res. 2015 Mar;115:21-38
pubmed: 25554382
Antimicrob Agents Chemother. 2021 Jun 17;65(7):e0009721
pubmed: 33903110
Anesth Prog. 2007 Spring;54(1):19-23; quiz 24-5
pubmed: 17352523
Hepatology. 2019 Sep;70(3):771-787
pubmed: 30964552
Molecules. 2020 Aug 27;25(17):
pubmed: 32867349
Hepatology. 2014 Jan;59(1):318-27
pubmed: 24115039
Antivir Ther. 2015;20(8):843-8
pubmed: 25849338
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
J Biomol Struct Dyn. 2021 Aug;39(13):4936-4948
pubmed: 32579061
Comput Biol Med. 2021 Jun;133:104359
pubmed: 33845270
Nat Commun. 2020 Jun 24;11(1):3202
pubmed: 32581217
Gene Rep. 2020 Dec;21:100860
pubmed: 32875166
Gastroenterology. 2016 Jul;151(1):70-86
pubmed: 27080301
Nature. 2020 Nov;587(7835):657-662
pubmed: 32726803
Gastroenterology. 2011 Mar;140(3):1032-42
pubmed: 21111742
Adv Enzyme Regul. 1984;22:27-55
pubmed: 6382953
Biosci Rep. 2020 Jun 26;40(6):
pubmed: 32441299
Sci Rep. 2020 Aug 17;10(1):13866
pubmed: 32807895
J Virol. 2002 Dec;76(24):13001-14
pubmed: 12438626
J Infect Dis. 2018 Oct 20;218(11):1722-1729
pubmed: 29982508
Nat Rev Microbiol. 2013 Jul;11(7):482-96
pubmed: 23748342
Nat Commun. 2020 Oct 15;11(1):5214
pubmed: 33060595
J King Saud Univ Sci. 2020 Sep;32(6):2845-2853
pubmed: 32837113
J Med Chem. 2020 Nov 13;:
pubmed: 33186044
J Hepatol. 2019 Mar;70(3):388-397
pubmed: 30395912
Science. 2020 Apr 24;368(6489):409-412
pubmed: 32198291
J Biomol Struct Dyn. 2020 Sep 4;:1-11
pubmed: 32885740
Eur J Pharmacol. 2020 Dec 15;889:173634
pubmed: 33031797
Antimicrob Agents Chemother. 2013 Mar;57(3):1291-303
pubmed: 23274664
Sci Rep. 2021 Jul 16;11(1):14571
pubmed: 34272426
Cell Rep. 2021 May 18;35(7):109133
pubmed: 33984267
Viruses. 2020 Apr 14;12(4):
pubmed: 32295237
Struct Chem. 2020 Jul 23;:1-22
pubmed: 32837118
JAMA Netw Open. 2020 Apr 1;3(4):e205619
pubmed: 32275319
Nature. 2020 Jun;582(7811):289-293
pubmed: 32272481
Life Sci. 2020 Oct 1;258:118205
pubmed: 32777300
J Biomol Struct Dyn. 2020 Jul 28;:1-16
pubmed: 32720571
Cell. 1996 Oct 18;87(2):343-55
pubmed: 8861917
Nat Med. 2013 Jul;19(7):837-49
pubmed: 23836234
J Biomol Struct Dyn. 2020 Jul 21;:1-11
pubmed: 32692306
N Engl J Med. 2020 Nov 5;383(19):1813-1826
pubmed: 32445440
Comb Chem High Throughput Screen. 2021;24(5):716-728
pubmed: 32798373
ACS Med Chem Lett. 2020 Oct 25;11(12):2526-2533
pubmed: 33324471
Drug Metab Dispos. 2014 Mar;42(3):394-406
pubmed: 24366904
Methods Mol Biol. 2019;1911:3-32
pubmed: 30593615
J Biomol Struct Dyn. 2020 Sep 2;:1-12
pubmed: 32873185
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508
J Virol. 2010 May;84(10):5277-93
pubmed: 20200247

Auteurs

Karen A Gammeltoft (KA)

Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital-Hvidovregrid.5254.6, Hvidovre, Denmark.
Copenhagen Hepatitis C Program (CO-HEP), Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagengrid.5254.6, Copenhagen, Denmark.

Yuyong Zhou (Y)

Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital-Hvidovregrid.5254.6, Hvidovre, Denmark.
Copenhagen Hepatitis C Program (CO-HEP), Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagengrid.5254.6, Copenhagen, Denmark.

Carlos R Duarte Hernandez (CR)

Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital-Hvidovregrid.5254.6, Hvidovre, Denmark.
Copenhagen Hepatitis C Program (CO-HEP), Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagengrid.5254.6, Copenhagen, Denmark.

Andrea Galli (A)

Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital-Hvidovregrid.5254.6, Hvidovre, Denmark.
Copenhagen Hepatitis C Program (CO-HEP), Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagengrid.5254.6, Copenhagen, Denmark.

Anna Offersgaard (A)

Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital-Hvidovregrid.5254.6, Hvidovre, Denmark.
Copenhagen Hepatitis C Program (CO-HEP), Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagengrid.5254.6, Copenhagen, Denmark.

Rui Costa (R)

Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital-Hvidovregrid.5254.6, Hvidovre, Denmark.
Copenhagen Hepatitis C Program (CO-HEP), Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagengrid.5254.6, Copenhagen, Denmark.

Long V Pham (LV)

Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital-Hvidovregrid.5254.6, Hvidovre, Denmark.
Copenhagen Hepatitis C Program (CO-HEP), Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagengrid.5254.6, Copenhagen, Denmark.

Ulrik Fahnøe (U)

Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital-Hvidovregrid.5254.6, Hvidovre, Denmark.
Copenhagen Hepatitis C Program (CO-HEP), Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagengrid.5254.6, Copenhagen, Denmark.

Shan Feng (S)

Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital-Hvidovregrid.5254.6, Hvidovre, Denmark.
Copenhagen Hepatitis C Program (CO-HEP), Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagengrid.5254.6, Copenhagen, Denmark.

Troels K H Scheel (TKH)

Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital-Hvidovregrid.5254.6, Hvidovre, Denmark.
Copenhagen Hepatitis C Program (CO-HEP), Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagengrid.5254.6, Copenhagen, Denmark.

Santseharay Ramirez (S)

Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital-Hvidovregrid.5254.6, Hvidovre, Denmark.
Copenhagen Hepatitis C Program (CO-HEP), Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagengrid.5254.6, Copenhagen, Denmark.

Jens Bukh (J)

Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital-Hvidovregrid.5254.6, Hvidovre, Denmark.
Copenhagen Hepatitis C Program (CO-HEP), Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagengrid.5254.6, Copenhagen, Denmark.

Judith M Gottwein (JM)

Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital-Hvidovregrid.5254.6, Hvidovre, Denmark.
Copenhagen Hepatitis C Program (CO-HEP), Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagengrid.5254.6, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH